Fibrinogen Binding Inhibitor Peptide

For research use only. Not for therapeutic Use.

  • CAT Number: I020196
  • CAS Number: 89105-94-2
  • Molecular Formula: C50H80N18O16
  • Molecular Weight: 1189.28
  • Purity: ≥95%
Inquiry Now

Fibrinogen Binding Inhibitor Peptide is a dodecapeptide (HHLGGAKQAGDV, H12), which is a fibrinogen γ-chain carboxy-terminal sequence (γ400-411). Fibrinogen Binding Inhibitor Peptide is a specific binding site of the ligand for activated glycoprotein (GP) IIb/IIIa.
Glycoprotein (GP) IIb/IIIa, which exists on the membrane of platelets, changes its form from inactive to active when platelets adhere to collagen exposed on sites of vascular injury. In the circulation, platelet aggregation is mediated by fibrinogen by bridging adjacent platelets through GPIIb/IIIa in an activation-dependent manner. A dodecapeptide HHLGGAKQAGDV (H12), corresponding to the fibrinogen γ-chain carboxy-terminal sequence (γ400-411), is a specific binding site of the ligand for activated GPIIb/IIIa[1].


Catalog Number I020196
CAS Number 89105-94-2
Molecular Formula C50H80N18O16
Purity ≥95%
Reference

[1]. Okamura Y, et al. Release abilities of adenosine diphosphate from phospholipid vesicles with different membraneproperties and their hemostatic effects as a platelet substitute. J Control Release. 2010 Dec 20;148(3):373-9.
 [Content Brief]

Request a Quote